The management of diabetic macular edema (DME) has been revolutionized in recent years. Focal and focal/grid laser photocoagulation have been the mainstay of treatment for DME for much time. However, nowadays, there is growing evidence that intravitreal VEGF-inhibitors (combined or not with laser photocoagulation) provide better visual outcome in patients with diabetic retinopathy. Hence, anti-VEGF injections are considered the new gold standard to treat diabetic macular edema and eyes with a reduced visual function. Further studies assessing different treatment regimens are underway to define better clinical care pathways.
Intravitreal Injections and Diabetic Macular Edema: Actual and New Therapeutic Options / Pescosolido, Nicola; Pranno, Federica; G., Buomprisco. - In: CURRENT DIABETES REVIEW. - ISSN 1573-3998. - STAMPA. - 9:6(2013), pp. 491-498. [10.2174/15733998113096660083]
Intravitreal Injections and Diabetic Macular Edema: Actual and New Therapeutic Options.
PESCOSOLIDO, Nicola;PRANNO, FEDERICA;
2013
Abstract
The management of diabetic macular edema (DME) has been revolutionized in recent years. Focal and focal/grid laser photocoagulation have been the mainstay of treatment for DME for much time. However, nowadays, there is growing evidence that intravitreal VEGF-inhibitors (combined or not with laser photocoagulation) provide better visual outcome in patients with diabetic retinopathy. Hence, anti-VEGF injections are considered the new gold standard to treat diabetic macular edema and eyes with a reduced visual function. Further studies assessing different treatment regimens are underway to define better clinical care pathways.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
